Category Archives: Business and Investments

Latest From Business and Investments

A beginner’s guide to mastering your 1×1 schedule

What to do when you’re a small biotech pony-ing up the big bucks to land your Phase II product on the radar of the world’s largest pharmaceutical companies? How to remain relevant and not get lost in the mix? A 2009 article by Nature Biotech entitled “Prepare to meet your partner” emphasizes the growing importance of partnering in today’s BD environment. Here are some crash course tips for you to maximize your partnering experience when Read More >

The One-on-One Compass  |  2 Comments  |  Email This Post
Tags: , ,

VC Fundraising Back to 2005 Levels

Is Venture Capital “holding up” for US biotech? Although there is a silver lining that venture capital fundraising for biotechnology outpaced other sectors in the US in 2009 and a number of new start-ups have been launched (see NVCA press release here), the multiyear trend is down. But by how much? I took a look at absolute numbers compiled by different sources to calculate where we are. The average is used because some sources include Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: ,

Where do you do your partnering?

Netbooks may have bridged the gap between laptops and mobile phones, at least for the time being (iPad or Windows Phone 7 anyone?).  However, where do you do your partnering?  Chances are it’s from your mobile computer a couple of days before the conference. Where you do partner?  Plane? Hotel room? Office?  I don’t partner…but my admin does? Check out the results of BIO’s unofficial survey into the matter.  By unofficial, I mean I made Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , ,

Posts from the 12th Annual BIO CEO & Investor Conference in New York (Feb 2010)

I created a new page on the blog (now called the “CONFERENCES” tab) where key takeaways from conference panels, speakers, etc., can be posted. My first three are now up from the business panels at last week’s 12th Annual BIO CEO & Investor Conference in New York: NOTES FROM THE M&A PANEL NOTES FROM THE FINANCING PANELS NOTES FROM THE ‘GOING COMMERCIAL’ PANEL -David Thomas

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: ,

BTK – A Decade of Change

Do you ever wonder what is really behind the often quoted BTK index (“NYSE Arca Biotechnology Index”)? Especially if it is the index you compare your own company’s stock with on a long term chart? If you compare your favorite biotech with the BTK over a 10 year period, here is what you are up against: CHANGE. When the last decade started, in the peak of the genomics bubble, the BTK was made up of Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , ,